Korea's only end-to-end SWCNT manufacturer

Next-gen cancer therapies powered by innate immunity.

Transforming drug development with SaaS.

Innovating sustained-release treatments for dementia, diabetes, and obesity.

Advancing Novel Therapies for Rare Diseases & Complex Generics for the U.S. Market

Hyperbaric oxygen therapy for medical and home use.

Advancing therapies for rare and tough diseases.

Pioneering the world’s first self-monitoring potassium device.

Korea’s first developer of messenger RNA therapeutics.

Targeting superbugs through cell-penetrating technology.

Developing novel peptide-based biomaterials